ArticleAsian journal of pharmaceutical sciences2022

Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy.

Hyemin Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.